Young sick african guy with fever blowing his nose and checking body temperature with thermometer, lying on couch

Lilly BLAZE-1 COVID-19 Treatment Study

Ages

12 and Older

Location

Columbus, OH

Compensation

Up to $3,050*
Young sick african guy with fever blowing his nose and checking body temperature with thermometer, lying on couch

COVID-19 Treatment Trials in Columbus

Aventiv Research is currently participating in the Eli Lilly BLAZE-1 COVID-19 treatment study at our Columbus, Ohio location.  If you or someone you know has tested positive within the last three days, learn more about participating. Compensation up to $3,050 may be available for qualified volunteers.

Enroll Now

Lilly BLAZE-1 COVID-19 Treatment Study

The primary objective of this clinical trial is to characterize the effect of an investigational drug, compared to placebo, on SARS-CoV-2 viral load and viral clearance.  You may qualify for this study if meet all the following criteria:

  • You are at least 12 years old
  • You are currently not hospitalized
  • You have one or more of the following symptoms:
    • Fever
    • Cough
    • Sore throat
    • Malaise (feeling unwell without an exact cause)
    • Headache
    • Muscle pain
    • Gastrointestinal (GI) symptoms, or
    • Shortness of breath.
  • You share your positive COVID-19 test results that was taken no more than 3 days before starting the drug infusion.

As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.

Ready to Volunteer?

Volunteer today to see if you qualify for our COVID-19 monoclonal antibody (mAb) treatment study. *Qualified volunteers may be compensated for time and travel.